You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prior Docetaxel Chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, NSCLC, Cervical Cancer Trial in China (Afuresertib, Nab paclitaxel, Docetaxel)

Recruiting
  • Solid Tumor
  • +5 more
  • Beijing, Beijing, China
  • +4 more
Jul 15, 2022

Advanced NSCLC Trial in Nanjing (AK104, Docetaxel)

Recruiting
  • Advanced Non-small Cell Lung Cancer
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Mar 24, 2022

Advanced NSCLC Trial in Yangzhou (camrelizumab + famitinib, famitinib, docetaxel)

Recruiting
  • Advanced NSCLC
  • camrelizumab + famitinib
  • +2 more
  • Yangzhou, Jiangsu, China
    Subei People's Hospital of Jiangsu Province
Jan 11, 2022

Non-Squamous NSCLC (NSCLC), Adenocarcinoma of the Lung, Lung Cancer Trial in United States (Docetaxel, Nivolumab, Gemcitabine)

Terminated
Has Results
  • Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
  • +3 more
  • Anderson, Indiana
  • +8 more
Jul 7, 2022

Advanced or Metastatic NSCLC Trial (Ceralasertib, Durvalumab, Docetaxel)

Recruiting
  • Advanced or Metastatic Non-Small Cell Lung Cancer
  • Chandler, Arizona
  • +80 more
Jan 12, 2023

Locally Advanced or Metastatic NSCLC Trial (Utidelone Injection, Docetaxel Injection)

Not yet recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • Utidelone Injection
  • Docetaxel Injection
  • (no location specified)
Dec 30, 2022

NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • MK-2870
  • +2 more
  • (no location specified)
Oct 3, 2023

Advanced NSCLC Trial (Trilaciclib+Envafolimab+Docetaxel, Envafolimab+Docetaxel, Docetaxel)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Jun 16, 2023

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,

Not yet recruiting
  • HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
  • PERT-IJS plus trastuzumab, carboplatin and docetaxel
  • Perjeta plus trastuzumab, carboplatin and docetaxel
  • (no location specified)
Sep 21, 2023

Lung Cancer, Non-Small Cell Trial in Worldwide (Cobolimab, Dostarlimab, Docetaxel)

Recruiting
  • Lung Cancer, Non-Small Cell
  • Cobolimab
  • +2 more
  • Fountain Valley, California
  • +106 more
Apr 12, 2022

Breast Tumors, Malignant Tumor of the Breast Trial in Multiple Locations (Trastuzumab, Pertuzumab, Vinorelbine, Paclitaxel,

Terminated
  • Breast Neoplasms
  • Malignant Tumor of the Breast
  • Multiple Locations, Texas
    19 Sites
Nov 29, 2022

Testicular Cancer Trial in Houston, Seattle (Gemcitabine, Docetaxel, Melphalan)

Active, not recruiting
  • Testicular Cancer
  • Houston, Texas
  • +1 more
Dec 5, 2022

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Stage III Breast Cancer AJCC V7 Trial in Bergen (epirubicin/docetaxel sequential)

Active, not recruiting
  • Stage III Breast Cancer AJCC V7
  • epirubicin/docetaxel sequential
  • Bergen, Norway
    Dept of Oncology
Jun 24, 2022

Locally Advanced Gastric Adenocarcinoma, Chemo Effect Trial in Hanzhou (Docetaxel, Tegafur-Gimeracil-Oteracil)

Recruiting
  • Locally Advanced Gastric Adenocarcinoma
  • Chemotherapy Effect
  • Hanzhou, Zhejiang, China
    Gastrointestinal Department of Second Affiliated Hospital of Zhe
Apr 2, 2023

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

Breast Cancer Trial (Utidelone Injection in combination with AC, Docetaxel Injection in combination with AC)

Not yet recruiting
  • Breast Cancer
  • Utidelone Injection in combination with AC
  • Docetaxel Injection in combination with AC
  • (no location specified)
Jan 10, 2023

Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)

Recruiting
  • Metastatic Hormone Naive Prostate Cancer
  • Sydney, New South Wales, Australia
  • +4 more
Nov 4, 2022

Gastric Cancer, Adjuvant Chemo, XO Trial in Seoul (Docetaxel and capecitabine and oxaliplatin, capecitabine and oxaliplatin)

Recruiting
  • Gastric Cancer, Adjuvant Chemotherapy, XO
  • Docetaxel and capecitabine and oxaliplatin
  • capecitabine and oxaliplatin
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 30, 2022

Breast Cancer, Chemo Effect Trial (Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel, Epirubicin, Cyclophosphamide,

Not yet recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel
  • Epirubicin, Cyclophosphamide, Docetaxel
  • (no location specified)
Jun 21, 2023

Docetaxel Ethanol-induced Symptoms; The Incidence and Risk

Completed
  • Breast Cancer
  • +6 more
    • Guri-si, Korea, Republic of
      Hanyang University Guri Hospital
    Jul 26, 2022

    NSCLC Trial in Changsha (Sintilimab Combined With Docetaxel)

    Completed
    • Non-small Cell Lung Cancer
    • Sintilimab Combined With Docetaxel
    • Changsha, Hunan, China
      Hunan Provincal Tumor Hospital
    Mar 1, 2022

    Prostate Cancer Trial in Madison (Docetaxel, Degarelix, Bicalutamide)

    Completed
    • Prostate Cancer
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Sep 12, 2022

    Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500

    Recruiting
    • Prevention of Chemotherapy-induced Myelosuppression
    • ALRN-6924
    • TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
    • Tamarac, Florida
    • +14 more
    Jan 31, 2023

    Squamous Cell Carcinoma, the Nasal Cavity, Paranasal Sinuses Trial in Houston (Pembrolizumab, Docetaxel, Cisplatin)

    Recruiting
    • Squamous Cell Carcinoma
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 10, 2022